TrialMolecular metabolism2018
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept.
Tamer Coskun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
422 papers cite itlatest 60 shown
this paperpooled ittrialcites it